268 related articles for article (PubMed ID: 5932017)
1. [The treatment of chronic hemoblastosis with new cytostatic agents].
Quattrin N
Minerva Med; 1966 Mar; 57(25):1141-3. PubMed ID: 5932017
[No Abstract] [Full Text] [Related]
2. [What is reliable in the therapy of hematologic diseases? I. Hemoblastosis and malignant lymphoproliferative diseases].
Havemann K; Schmidt M; Malchow H; Sodomann CP
Internist (Berl); 1970 Dec; 11(12):441-9. PubMed ID: 4993105
[No Abstract] [Full Text] [Related]
3. [Clinical research on the antipyretic effects of indomethacin in systemic hemopathies].
Marcolongo R; Bianco G; Di Paolo N; Bravi A
Minerva Med; 1970 Oct; 61(82):4532-41. PubMed ID: 5273365
[No Abstract] [Full Text] [Related]
4. Long-term perspective of hematologic malignancies.
Cheson BD
Trans Assoc Life Insur Med Dir Am; 1988; 71():198-220. PubMed ID: 3285568
[No Abstract] [Full Text] [Related]
5. [Results of cytostatic therapy of malignant hemoblastoses].
Stacher A
Wien Z Inn Med; 1966 Jan; 47(1):1-16. PubMed ID: 4962311
[No Abstract] [Full Text] [Related]
6. [Principles of treatment of hemoblastoses under ambulatory conditions].
Polonskaia EN; Vinogradova IuE; Lobanova NA; Iudina NI; Korovina VI
Ter Arkh; 1976; 48(8):54-60. PubMed ID: 828780
[No Abstract] [Full Text] [Related]
7. Chemotherapy of Hodgkin's disease, lymphoma, and leukemia.
Bishop RC
Radiol Clin North Am; 1968 Apr; 6(1):91-5. PubMed ID: 5652936
[No Abstract] [Full Text] [Related]
8. [Rehabilitation and cure of patients with hemoblastoses].
Gerhartz H
Dtsch Med J; 1968 Mar; 19(5):161-3. PubMed ID: 4887782
[No Abstract] [Full Text] [Related]
9. [Malignant blood diseases during pregnancy].
Killander A
Lakartidningen; 1977 May; 74(18):1828-9. PubMed ID: 853815
[No Abstract] [Full Text] [Related]
10. [Current therapy of malignant blood diseases].
de Werra P
Praxis; 1967 Jun; 56(26):901-6. PubMed ID: 5253422
[No Abstract] [Full Text] [Related]
11. [Quantitative immunoglobulin determination as a monitoring technic in hematologic diseases under cytostatic therapy].
Knolle J; Wörz R; Meyer zum Büschenfelde
Verh Dtsch Ges Inn Med; 1969; 75():492-7. PubMed ID: 4099583
[No Abstract] [Full Text] [Related]
12. [Rituximab. A monoclonal CD20 antibody--hematological indications and possible treatments for immunoinflammatory diseases].
Hansen PB; Hasselbalch HC
Ugeskr Laeger; 2004 Feb; 166(6):466-9. PubMed ID: 15045710
[No Abstract] [Full Text] [Related]
13. [General aspects of cytostatic therapy of hemoblastoses].
Rieche K
Z Gesamte Inn Med; 1976 Apr; 31(8):217-21. PubMed ID: 960899
[TBL] [Abstract][Full Text] [Related]
14. [Evaluation of the serum lysozyme level as a further parameter for predicting hematological tolerance in patients treated with cytostatic chemotherapy. Study of 134 cases].
Neretto G; Agricola R; Giovanelli E; Poccardi G; Pellerito R; Furno F; Martinetto P; Pellegrino S; Daglio C; Tondolo M
Recenti Prog Med; 1980 Oct; 69(4):431-57. PubMed ID: 7006015
[No Abstract] [Full Text] [Related]
15. [Indomethacin in hemoblastosis].
Treske U
Arzneimittelforschung; 1971 Nov; 21(11):1832-3. PubMed ID: 4944970
[No Abstract] [Full Text] [Related]
16. [Recent cytostatic therapy in hemoblastosis and malignant tumors].
Kühböck J; Mannheimer E
Wien Klin Wochenschr; 1966 Jul; 78(26):487-8. PubMed ID: 5992456
[No Abstract] [Full Text] [Related]
17. Leukaemia and lymphoma: the prospect of control.
Hayhoe FG
Schweiz Med Wochenschr; 1974 Dec; 104(51):1897-907. PubMed ID: 4612705
[No Abstract] [Full Text] [Related]
18. [Cytostatic polychemotherapy in the elderly].
Heinz R
Dtsch Med Wochenschr; 1986 May; 111(19):761-2. PubMed ID: 3698857
[No Abstract] [Full Text] [Related]
19. [Drugs needed for treatment of patients with hemoblastosis].
Lebedev VN; Sarkisian SP
Probl Gematol Pereliv Krovi; 1977 Jun; 22(6):45-8. PubMed ID: 877053
[No Abstract] [Full Text] [Related]
20. Children are surviving leukemia and lymphoma.
Isler C
RN; 1975 Nov; 38(11):20-5. PubMed ID: 1043102
[No Abstract] [Full Text] [Related]
[Next] [New Search]
